Riso Pharmaceuticals International
Bioadvantex
Urixin
Silexin
Biolyse
Paclitaxel
BioSyent Inc.
FeraMAX
Feldan
Glenwood
Helsinn
Gelclair
Klean-Prep
Nasaleze Ltd.
Nasaleze
Omega laboratories
Pamidronate
PISA
Serral Laboratories
Stella Pharmaceutical Canada Inc.
Kolik-Gripe Water
Unigene
Fortical
 
Silexin

 

Silexin
What is Silexin?

SILEXIN is a daily multi vitamin-mineral supplement with key antioxidants specifically formulated for prostate health. SILEXIN is recommended by Urologists throughout North America as a proactive approach to long-term prostate health care.

SILEXIN contains the 5 key ingredients for effective support of prostate health: Lycopene, Vitamin D3, Selenium, Decaffeinated Green Tea Leaf Extract, and Vitamin E. The dosages of the key ingredients found in SILEXIN carefully match the doses studied in various key scientific research and clinical trials in North America and Europe, which found significant improvement of overall prostate health.

Who Can Benefit From SILEXIN?

All adult males (with or without prostate concerns) can benefit from the ingredients in SILEXIN. Studies have found that risk factors such as age, race, family history and dietary factors are associated with prostate problems. Among all leading health issues for men, two out of six involve the prostate.
Many scientific research and clinical trials conducted in Europe and North America have confirmed the effectiveness of the ingredients in SILEXIN for significant improvement of prostate health. The beneficial effects of Lycopene, found in tomatoes and Green Tea Leaf Extracts have caused the medical and biochemical community to focus a great deal of attention on diets and dietary supplements containing these two ingredients and consequently research activities have increased dramatically over the last few years.

Be proactive about your prostate health today with SILEXIN.

More Information ...

 
 

Riso Pharma Tech is a Canadian-based specialty pharmaceutical company focused on in-licensing late-stage and approved molecules for marketing and sales in Canada, certain European Union countries, Latin America, and the Middle East.

 

From large multi-national pharmaceutical companies to small biotechs, Riso's license deals have yielded successful product launches in its territories. Five regional offices and over 360 employees worldwide enable Riso to extend the reach of our partner companies' products.

 

With an extensive track record of greater than 10+ years marketing and sales success in its territories, and thanks to Riso's financial strength, Riso is aggressively pursuing new in-licensing opportunities across several therapeutic areas: oncology, supportive care, neurology, endocrinology and women's health.